Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 15, 2011, Pages 6235-6240

  Kondo, Jumpei ^a,b   Endo, Hiroko ^a   Okuyama, Hiroaki ^a   Ishikawa, Osamu ^a   Iishi, Hiroyasu ^a   Tsujii, Masahiko ^b   Ohue, Masayuki ^a   Inoue, Masahiro ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Colon; Drug sensitivity

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER CELL CULTURE; CANCER SURVIVAL; CANCER TISSUE; CELL ADHESION; CHEMOSENSITIVITY; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; DISSOCIATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPHEROID CELL; STEM CELL EXPANSION;

MUS;

EID: 79955009779     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1015938108     Document Type: Article

References (39)

1. Shoemaker RH (2006) The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 6:813-823. (Pubitemid 44450469)
2. Bernards R (2010) It's diagnostics, stupid. Cell 141:13-17.
3. Samson DJ, Seidenfeld J, Ziegler K, Aronson N (2004) Chemotherapy sensitivity and resistance assays: A systematic review. J Clin Oncol 22:3618-3630. (Pubitemid 41103669)
4. Yoshida T, et al. (2008) Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk. Int J Cancer 122:1530-1538. (Pubitemid 351294961)
5. Birgersdotter A, Sandberg R, Ernberg I (2005) Gene expression perturbation in vitro- a growing case for three-dimensional (3D) culture systems. Semin Cancer Biol 15: 405-412. (Pubitemid 41140308)
6. Lee J, et al. (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9:391-403. (Pubitemid 43668737)
7. Ochs RL, et al. (2003) Evidence for the isolation, growth, and characterization of malignant cells in primary cultures of human tumors. In Vitro Cell Dev Biol Anim 39: 63-70. (Pubitemid 36944611)
8. Hall PA, Coates PJ, Ansari B, Hopwood D (1994) Regulation of cell number in the mammalian gastrointestinal tract: The importance of apoptosis. J Cell Sci 107:3569-3577.
9. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
10. Hofmann C, et al. (2007) Cell-cell contacts prevent anoikis in primary human colonic epithelial cells. Gastroenterology 132:587-600. (Pubitemid 46274657)
11. Frisch SM, Francis H (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124:619-626. (Pubitemid 24064472)
12. Chiarugi P, Giannoni E (2008) Anoikis: A necessary death program for anchoragedependent cells. Biochem Pharmacol 76:1352-1364.
13. Kang HG, et al. (2007) E-cadherin cell-cell adhesion in Ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res 67: 3094-3105.
14. Kantak SS, Kramer RH (1998) E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem 273:16953-16961. (Pubitemid 28311727)
15. Shapiro AM, et al. (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238. (Pubitemid 30490390)
16. Langer RM (2010) Islet transplantation: Lessons learned since the Edmonton breakthrough. Transplant Proc 42:1421-1424.
17. Pece S, Chiariello M, Murga C, Gutkind JS (1999) Activation of the protein kinase Akt/ PKB by the formation of E-cadherin-mediated cell-cell junctions. Evidence for the association of phosphatidylinositol 3-kinase with the E-cadherin adhesion complex. J Biol Chem 274:19347-19351.
18. De Santis G, Miotti S, Mazzi M, Canevari S, Tomassetti A (2009) E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells. Oncogene 28:1206-1217.
19. West NP, et al. (2010) The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. Br J Cancer 102:1519-1523.
20. Ohue M, et al. (1994) A frequent alteration of p53 gene in carcinoma in adenoma of colon. Cancer Res 54:4798-4804. (Pubitemid 24276515)
21. Iacopetta B (2003) TP53 mutation in colorectal cancer. Hum Mutat 21:271-276. (Pubitemid 36292968)
22. Allegra CJ, et al. (2009) American Society of Clinical Oncology provisional clinical opinion: Testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol 27:2091-2096.
23. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4:988-1004.
24. Lawlor MA, Alessi DR (2001) PKB/Akt: A key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114:2903-2910. (Pubitemid 32821530)
25. Fang JY, Richardson BC (2005) The MAPK signalling pathways and colorectal cancer. Lancet Oncol 6:322-327. (Pubitemid 40590269)
26. Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA (2009) Spheroid-based drug screen: Considerations and practical approach. Nat Protoc 4:309-324.
27. Souliéres D, et al. (2010) KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies. Curr Oncol 17(Suppl 1):S31-S40.
28. Hilska M, et al. (1998) The distribution of collagen types I, III, and IV in normal and malignant colorectal mucosa. Eur J Surg 164:457-464. (Pubitemid 28298249)
29. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-110. (Pubitemid 46067310)
30. Ricci-Vitiani L, et al. (2007) Identification and expansion of human colon-cancerinitiating cells. Nature 445:111-115. (Pubitemid 46067311)
31. Tsanou E, Peschos D, Batistatou A, Charalabopoulos A, Charalabopoulos K (2008) The E-cadherin adhesion molecule and colorectal cancer. A global literature approach. Anticancer Res 28(6A):3815-3826.
32. Hugh TJ, et al. (1999) Cadherin-catenin expression in primary colorectal cancer: A survival analysis. Br J Cancer 80:1046-1051. (Pubitemid 29233927)
33. Ilyas M, et al. (1997) Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes' B colorectal cancers. J Clin Pathol 50:218-222. (Pubitemid 27122800)
34. Mueller-KlieserW(1997) Three-dimensional cell cultures: From molecular mechanisms to clinical applications. Am J Physiol 273:C1109-C1123. (Pubitemid 127797683)
35. Weiswald LB, et al. (2009) Newly characterised ex vivo colospheres as a threedimensional colon cancer cell model of tumour aggressiveness. Br J Cancer 101:473-482.
36. Vermeulen L, et al. (2008) Single-cell cloning of colon cancer stem cells reveals a multilineage differentiation capacity. Proc Natl Acad Sci USA 105:13427-13432.
37. Burdall SE, Hanby AM, Lansdown MR, Speirs V (2003) Breast cancer cell lines: Friend or foe? Breast Cancer Res 5:89-95. (Pubitemid 36348102)
38. Gusterson BA, et al. (1982) Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res 42:4763-4770. (Pubitemid 13205987)
39. Haslam SZ, Drolet A, Smith K, TanM, AupperleeM(2008) Progestin-regulated luminal cell and myoepithelial cell-specific responses in mammary organoid culture. Endocrinology 149:2098-2107. (Pubitemid 351574529)